142 related articles for article (PubMed ID: 1313156)
1. The effect of benzodiazepines on the binding of [3H]SCH 23390 in vivo.
Inoue O; Kobayashi K; Sakiyama Y; Suzuki T
Neuropharmacology; 1992 Feb; 31(2):115-21. PubMed ID: 1313156
[TBL] [Abstract][Full Text] [Related]
2. In vivo binding of (3H)Ro 15-1788 in mice: comparison with the in vivo binding of (3H)flunitrazepam.
Potier MC; Prado de Carvalho L; Dodd RH; Brown CL; Rossier J
Life Sci; 1988; 43(16):1287-96. PubMed ID: 2845217
[TBL] [Abstract][Full Text] [Related]
3. Effects of the GABAergic system on in vivo binding of [3H]N-methylspiperone.
Nakano T; Kobayashi K; Hosoi R; Wakahara S; Watanabe Y; Nishimura T; Inoue O
Neuropharmacology; 1998; 37(3):375-81. PubMed ID: 9681935
[TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.
Möhler H; Burkard WP; Keller HH; Richards JG; Haefely W
J Neurochem; 1981 Sep; 37(3):714-22. PubMed ID: 6268754
[TBL] [Abstract][Full Text] [Related]
5. An increase in the in vivo binding of [3H]SCH 23390 induced by MK-801 in the mouse striatum.
Kobayashi K; Inoue O
Neuropharmacology; 1993 Apr; 32(4):341-8. PubMed ID: 8497337
[TBL] [Abstract][Full Text] [Related]
6. Chronic benzodiazepine antagonist treatment and its withdrawal upregulates components of GABA-benzodiazepine receptor ionophore complex in cerebral cortex of rat.
Kulkarni SK; Ticku MK
Brain Res; 1990 Jun; 519(1-2):6-11. PubMed ID: 2168788
[TBL] [Abstract][Full Text] [Related]
7. Kinetic differences between type I and type II benzodiazepine receptors.
Trifiletti RR; Lo MM; Snyder SH
Mol Pharmacol; 1984 Sep; 26(2):228-40. PubMed ID: 6090882
[TBL] [Abstract][Full Text] [Related]
8. The effect of cyclopyrrolones on GABAA receptor function is different from that of benzodiazepines.
Concas A; Serra M; Santoro G; Maciocco E; Cuccheddu T; Biggio G
Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):294-300. PubMed ID: 7824046
[TBL] [Abstract][Full Text] [Related]
9. Conformational changes in benzodiazepine receptors induced by the antagonist Ro 15-1788.
Chiu TH; Rosenberg HC
Mol Pharmacol; 1983 Mar; 23(2):289-94. PubMed ID: 6300640
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic cyclopyrrolones zopiclone and suriclone bind to a novel site linked allosterically to benzodiazepine receptors.
Trifiletti RR; Snyder SH
Mol Pharmacol; 1984 Nov; 26(3):458-69. PubMed ID: 6092896
[TBL] [Abstract][Full Text] [Related]
11. Increased binding of [3H]muscimol and [3H]flunitrazepam in the rat brain under hypoxia.
Ninomiya H; Taniguchi T; Kameyama M; Fujiwara M
J Neurochem; 1988 Oct; 51(4):1111-7. PubMed ID: 2843604
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a benzodiazepine receptor site with exceptionally high affinity for Ro 15-4513 in the rat CNS.
Mehta AK; Shank RP
Brain Res; 1995 Dec; 704(2):289-97. PubMed ID: 8788925
[TBL] [Abstract][Full Text] [Related]
13. In vivo and in vitro modulation of central type benzodiazepine receptors by phosphatidylserine.
Levi de Stein M; Medina JH; De Robertis E
Brain Res Mol Brain Res; 1989 Jan; 5(1):9-15. PubMed ID: 2538706
[TBL] [Abstract][Full Text] [Related]
14. Effect of diethyl pyrocarbonate modification of benzodiazepine receptors on [3H]Ro 15-4513 binding.
Uusi-Oukari M
J Neurochem; 1992 Aug; 59(2):560-7. PubMed ID: 1321230
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine receptors in human brain: characterization, subcellular localization and solubilization.
Maloteaux JM; Octave JN; Vanisberg MA; Kollmann P; Ackermans A; Laterre C
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):773-82. PubMed ID: 2851861
[TBL] [Abstract][Full Text] [Related]
16. Reserpine-induced reduction of in vivo binding of SCH 23390 and N-methylspiperone and its reversal by d-amphetamine.
Inoue O; Tsukada H; Yonezawa H; Suhara T; Langstrom B
Eur J Pharmacol; 1991 May; 197(2-3):143-9. PubMed ID: 1915566
[TBL] [Abstract][Full Text] [Related]
17. In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.
Benavides J; Peny B; Dubois A; Perrault G; Morel E; Zivkovic B; Scatton B
J Pharmacol Exp Ther; 1988 Jun; 245(3):1033-41. PubMed ID: 2838599
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to Ro 15-1788: differential effect on flunitrazepam binding to cortex and hippocampus.
Urbancic M; Marczynski TJ
Eur J Pharmacol; 1989 Nov; 171(1):1-7. PubMed ID: 2515067
[TBL] [Abstract][Full Text] [Related]
19. [3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs.
Koe BK; Kondratas E; Russo LL
Eur J Pharmacol; 1987 Oct; 142(3):373-84. PubMed ID: 2892685
[TBL] [Abstract][Full Text] [Related]
20. Discrepancy between cell injury and benzodiazepine receptor binding after transient middle cerebral artery occlusion in rats.
Abe K; Kashiwagi Y; Tokumura M; Hosoi R; Hatazawa J; Inoue O
Synapse; 2004 Sep; 53(4):234-9. PubMed ID: 15266555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
